134 related articles for article (PubMed ID: 35215244)
1. Aescin Protects against Experimental Benign Prostatic Hyperplasia and Preserves Prostate Histomorphology in Rats via Suppression of Inflammatory Cytokines and COX-2.
Raafat M; Kamel AA; Shehata AH; Ahmed AF; Bayoumi AMA; Moussa RA; Abourehab MAS; El-Daly M
Pharmaceuticals (Basel); 2022 Jan; 15(2):. PubMed ID: 35215244
[TBL] [Abstract][Full Text] [Related]
2. Asteris Radix et Rhizoma suppresses testosterone-induced benign prostatic hyperplasia in rats by regulating apoptosis and inflammation.
Rho J; Seo CS; Park HS; Jeong HY; Moon OS; Seo YW; Son HY; Won YS; Kwun HJ
J Ethnopharmacol; 2020 Jun; 255():112779. PubMed ID: 32209388
[TBL] [Abstract][Full Text] [Related]
3. Immunomodulatory effect of diallyl sulfide on experimentally-induced benign prostate hyperplasia via the suppression of CD4+T/IL-17 and TGF-β1/ERK pathways.
Elbaz EM; Amin HAA; Kamel AS; Ibrahim SM; Helmy HS
Inflammopharmacology; 2020 Oct; 28(5):1407-1420. PubMed ID: 32785828
[TBL] [Abstract][Full Text] [Related]
4. Effect of gold nanoparticles treatment on the testosterone-induced benign prostatic hyperplasia in rats.
Al-Trad B; Aljabali A; Al Zoubi M; Shehab M; Omari S
Int J Nanomedicine; 2019; 14():3145-3154. PubMed ID: 31118628
[No Abstract] [Full Text] [Related]
5.
Elsherbini DMA; Almohaimeed HM; El-Sherbiny M; Mohammedsaleh ZM; Elsherbiny NM; Gabr SA; Ebrahim HA
Antioxidants (Basel); 2022 Jun; 11(6):. PubMed ID: 35740046
[TBL] [Abstract][Full Text] [Related]
6. Abacopteris penangiana exerts testosterone-induced benign prostatic hyperplasia protective effect through regulating inflammatory responses, reducing oxidative stress and anti-proliferative.
Yang X; Yuan L; Xiong C; Yin C; Ruan J
J Ethnopharmacol; 2014 Nov; 157():105-13. PubMed ID: 25260581
[TBL] [Abstract][Full Text] [Related]
7. Common salt aggravated pathology of testosterone-induced benign prostatic hyperplasia in adult male Wistar rat.
Bello II; Omigbodun A; Morhason-Bello I
BMC Urol; 2023 Dec; 23(1):207. PubMed ID: 38082261
[TBL] [Abstract][Full Text] [Related]
8. Inhibitory Effect of Thymoquinone on Testosterone-Induced Benign Prostatic Hyperplasia in Wistar Rats.
Al-Trad B; Al-Zoubi M; Qar J; Al-Batayneh K; Hussien E; Muhaidat R; Aljabali A; Alkhateeb H; Al Omari G
Phytother Res; 2017 Dec; 31(12):1910-1915. PubMed ID: 28960541
[TBL] [Abstract][Full Text] [Related]
9. Inhibitory effects of Ponciri Fructus on testosterone-induced benign prostatic hyperplasia in rats.
Jeon WY; Kim OS; Seo CS; Jin SE; Kim JA; Shin HK; Kim YU; Lee MY
BMC Complement Altern Med; 2017 Aug; 17(1):384. PubMed ID: 28774334
[TBL] [Abstract][Full Text] [Related]
10. Linh Phu Khang Tue Tinh inhibited prostate proliferation in rats induced benign prostatic hyperplasia by testosterone propionate.
Minh TD; Thanh Ha TN; Duy TN; Hoang NN; PhamTien D; Thai HP; Thi HN; Thi Lan PD; Quoc BP; Ivkin DY; Povydysh MN; Cong BN; Krasnova MV
J Ethnopharmacol; 2021 Oct; 279():114388. PubMed ID: 34224813
[TBL] [Abstract][Full Text] [Related]
11. Cyclooxygenase-2 activates EGFR-ERK1/2 pathway via PGE2-mediated ADAM-17 signaling in testosterone-induced benign prostatic hyperplasia.
Abo-El Fetoh ME; Abdel-Fattah MM; Mohamed WR; Ramadan LAA; Afify H
Inflammopharmacology; 2023 Feb; 31(1):499-516. PubMed ID: 36586043
[TBL] [Abstract][Full Text] [Related]
12. Dapoxetine attenuates testosterone-induced prostatic hyperplasia in rats by the regulation of inflammatory and apoptotic proteins.
Sayed RH; Saad MA; El-Sahar AE
Toxicol Appl Pharmacol; 2016 Nov; 311():52-60. PubMed ID: 27687055
[TBL] [Abstract][Full Text] [Related]
13. Amelioration of testosterone induced benign prostatic hyperplasia by Prunus species.
Jena AK; Vasisht K; Sharma N; Kaur R; Dhingra MS; Karan M
J Ethnopharmacol; 2016 Aug; 190():33-45. PubMed ID: 27235020
[TBL] [Abstract][Full Text] [Related]
14. Diacerein ameliorates testosterone-induced benign prostatic hyperplasia in rats: Effect on oxidative stress, inflammation and apoptosis.
El-Sherbiny M; El-Shafey M; El-Din El-Agawy MS; Mohamed AS; Eisa NH; Elsherbiny NM
Int Immunopharmacol; 2021 Nov; 100():108082. PubMed ID: 34450401
[TBL] [Abstract][Full Text] [Related]
15. Amelioration of testosterone-induced benign prostatic hyperplasia using febuxostat in rats: The role of VEGF/TGFβ and iNOS/COX-2.
Abdel-Aziz AM; Gamal El-Tahawy NF; Salah Abdel Haleem MA; Mohammed MM; Ali AI; Ibrahim YF
Eur J Pharmacol; 2020 Dec; 889():173631. PubMed ID: 33031799
[TBL] [Abstract][Full Text] [Related]
16. Inhibitory effects of Tripterygium wilfordii multiglycoside on benign prostatic hyperplasia in rats.
Shen HN; Xu Y; Jiang ZZ; Huang X; Zhang LY; Wang T
Chin J Nat Med; 2015 Jun; 13(6):421-7. PubMed ID: 26073338
[TBL] [Abstract][Full Text] [Related]
17. Role of PPAR-α agonist fenofibrate in the treatment of induced benign prostatic hyperplasia with dysplastic changes in rats.
Refaie MMM; Rifaai RA; Zenhom NM
Fundam Clin Pharmacol; 2018 Dec; 32(6):617-626. PubMed ID: 29862557
[TBL] [Abstract][Full Text] [Related]
18. Inhibitory Effect of Artemisinin on Testosterone Propionate Induced Benign Prostatic Hyperplasia.
Solanki A; Patel S; Solanki N; Shah U
Curr Drug Discov Technol; 2021; 18(4):518-524. PubMed ID: 32532194
[TBL] [Abstract][Full Text] [Related]
19. Potential ameliorative effects of epigallocatechin‑3‑gallate against testosterone-induced benign prostatic hyperplasia and fibrosis in rats.
Zhou J; Lei Y; Chen J; Zhou X
Int Immunopharmacol; 2018 Nov; 64():162-169. PubMed ID: 30179845
[TBL] [Abstract][Full Text] [Related]
20. Effects of Melandrium firmum methanolic extract on testosterone-induced benign prostatic hyperplasia in Wistar rats.
Lee MY; Shin IS; Seo CS; Lee NH; Ha HK; Son JK; Shin HK
Asian J Androl; 2012 Mar; 14(2):320-4. PubMed ID: 22231294
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
